“All of the things to everyone everywhere”: A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19

BACKGROUND: Neutralizing monoclonal antibody (mAb) treatment for COVID-19 prevents hospitalization and death but is underused, especially in racial/ethnic minority and rural populations. Reasons for underuse and inequity may include community member lack of awareness or healthcare access barriers, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwan, Bethany M., Sobczak, Chelsea, Gorman, Carol, Roberts, Samantha, Owen, Vanessa, Wynia, Matthew K., Ginde, Adit A., Pena-Jackson, Griselda, Ziegler, Owen, Ross DeCamp, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683597/
https://www.ncbi.nlm.nih.gov/pubmed/36417457
http://dx.doi.org/10.1371/journal.pone.0274043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683597/
https://www.ncbi.nlm.nih.gov/pubmed/36417457
http://dx.doi.org/10.1371/journal.pone.0274043

Ejemplares similares